» Articles » PMID: 7911719

Functional Studies on Alpha 1-adrenoceptor Subtypes Mediating Inotropic Effects in Rat Right Ventricle

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1994 Feb 1
PMID 7911719
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

1. We have studied the alpha 1-adrenoceptor subtypes mediating inotropic effects of adrenaline in rat right ventricle and the Ca2+ sources used to elicit these effects. alpha 1A-Adrenoceptor-mediated contractile effects in rat vas deferens were studied for comparison in some cases. 2. Treatment with chloroethylclonidine did not affect the maximal beta-adrenoceptor-mediated inotropic effects in rat right ventricle or the maximal alpha 1A-adrenoceptor-mediated contractile effects in rat vas deferens; it did not alter the potency of isoprenaline in the ventricle and reduced the potency of the alpha-adrenoceptor antagonists in vas deferens only slightly. Treatment of right ventricular strips with CdCl2 markedly reduced resting tension and enhanced maximal inotropic effects of isoprenaline but did not affect its potency. 3. Inactivation of cardiac alpha 1B-adrenoceptors by treatment with chloroethylclonidine slightly enhanced the maximal inotropic effects of the full agonist, adrenaline and of several partial agonists. 4. Schild analysis of inhibition experiments with the alpha 1A-adrenoceptor-selective antagonists, 5-methyl-urapidil and (+/-)-tamsulosin, demonstrated that adrenaline causes its inotropic effects mainly via the alpha 1B-adrenoceptor subtype. Schild analysis of 5-methyl-urapidil inhibition experiments in chloroethylclonidine-treated ventricles indicated that only alpha 1A-adrenoceptors mediate the inotropic effects of adrenaline following inactivation of the alpha 1B-adrenoceptors. 5. In control ventricles the organic Ca2+ entry blocker, nitrendipine and treatment with the inorganic Ca2+ entry blocker, CdCl2 did not reduce inotropic effects of adrenaline whereas ryanodine treatment inhibited them. In contrast, nitrendipine and CdCl2 treatment had major inhibitory effects in chloroethylclonidine-treated but lacked inhibitory effects in phenoxybenzamine-treated ventricular strips. 6. We conclude that inotropic effects of adrenaline in rat heart are mediated mainly by alpha 1B-adrenoceptors via release of Ca2+ from an intracellular pool. Following inactivation of alpha 1B-adrenoceptors by chloroethylclonidine treatment, alpha lA-adrenoceptors can fully compensate and mediate inotropic effects by promoting influx of extracellular Ca2+ at least partly via voltage-operated channels.Therefore, we speculate that alpha 1B-adrenoceptors exert a tonic inhibitory effect on alpha 1A-adrenoceptors.

Citing Articles

Cardiac and Vascular α-Adrenoceptors in Congestive Heart Failure: A Systematic Review.

Kayki-Mutlu G, Papazisi O, Palmen M, Danser A, Michel M, Arioglu-Inan E Cells. 2020; 9(11).

PMID: 33158106 PMC: 7694190. DOI: 10.3390/cells9112412.


The role of α- and α-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats.

Rivera-Mancilla E, Aviles-Rosas V, Manrique-Maldonado G, Altamirano-Espinoza A, Villanueva-Castillo B, MaassenVanDenBrink A J Headache Pain. 2017; 18(1):104.

PMID: 29022279 PMC: 5636772. DOI: 10.1186/s10194-017-0812-4.


Pharmacological characterization of ergotamine-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats.

Cobos-Puc L, Villalon C, Sanchez-Lopez A, Ramirez-Rosas M, Lozano-Cuenca J, Pertz H Naunyn Schmiedebergs Arch Pharmacol. 2008; 379(2):137-48.

PMID: 18779954 DOI: 10.1007/s00210-008-0339-y.


Alpha1-adrenoceptors and ejaculatory function.

Michel M Br J Pharmacol. 2007; 152(3):289-90.

PMID: 17603543 PMC: 2042961. DOI: 10.1038/sj.bjp.0707369.


Rolipram reduces the inotropic tachyphylaxis of glucagon in rat ventricular myocardium.

Juan-Fita M, Vargas M, Kaumann A, Hernandez Cascales J Naunyn Schmiedebergs Arch Pharmacol. 2004; 370(4):324-9.

PMID: 15452686 DOI: 10.1007/s00210-004-0978-6.


References
1.
Brodde O, Michel M . Adrenergic receptors and their signal transduction mechanisms in hypertension. J Hypertens Suppl. 1992; 10(7):S133-45. View

2.
Stern M, Lakatta E . Excitation-contraction coupling in the heart: the state of the question. FASEB J. 1992; 6(12):3092-100. DOI: 10.1096/fasebj.6.12.1325933. View

3.
Michel M, Buscher R, Kerker J, Kraneis H, Erdbrugger W, Brodde O . Alpha 1-adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy. Evidence for heterogeneity of chloroethylclonidine-resistant rat renal alpha 1-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol. 1993; 348(4):385-95. DOI: 10.1007/BF00171338. View

4.
Michel M, Hanft G, Gross G . Radioligand binding studies of alpha 1-adrenoceptor subtypes in rat heart. Br J Pharmacol. 1994; 111(2):533-8. PMC: 1909949. DOI: 10.1111/j.1476-5381.1994.tb14770.x. View

5.
ARUNLAKSHANA O, SCHILD H . Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959; 14(1):48-58. PMC: 1481829. DOI: 10.1111/j.1476-5381.1959.tb00928.x. View